Therapy-related myeloid leukemia during erlotinib treatment in a non-small cell lung cancer patient: A case report

doi:10.12998/wjcc.v9.i24.7205

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 24

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4127)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

263

WORD

HTML

1872

Figures (1-2)

282

Tables (1-1)

278

Sum=2785

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

361

Download

981

Sum=1342

Aug 26, 2021 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Aug 26, 2021; 9(24): 7205-7211
Published online Aug 26, 2021. doi: 10.12998/wjcc.v9.i24.7205

Full Size Figure Download Figure

Figure 1 Blood smear and bone marrow aspiration results. A: The blood smear shows 44% blast cells (× 1000); B: The bone marrow aspiration showed 77.3% myoblasts (× 1000).

Citation: Koo SM, Kim KU, Kim YK, Uh ST. Therapy-related myeloid leukemia during erlotinib treatment in a non-small cell lung cancer patient: A case report. World J Clin Cases 2021; 9(24): 7205-7211
URL: https://www.wjgnet.com/2307-8960/full/v9/i24/7205.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i24.7205